UnknownNot Applicable

Barrow Ruptured Aneurysm Trial

United States500 participantsStarted 2002-11

Plain-language summary

With evolving endovascular technologies there is a growing debate centered on the relative safety and efficacy of the currently accepted alternatives for the treatment of ruptured cerebral aneurysms in the face of acute subarachnoid hemorrhage (SAH). The purpose of this study is to compare the safety and efficacy of microsurgical clipping and endovascular coiling of acutely ruptured cerebral aneurysms in a prospective, randomized fashion.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute subarachnoid hemorrhage (SAH) * Confirmed by CT scan or lumbar puncture * Age 18-80 years * Ability to give informed consent (subject or legally authorized representative) * No anatomic inclusions Exclusion Criteria: * Traumatic subarachnoid hemorrhage * Presents to hospital \>14 days post-bleed * SAH caused by other primary disease * No anatomic exclusions

What they're measuring

Modified Rankin Scale

Timeframe: 10 years

Trial details

NCT IDNCT01593267

SponsorSt. Joseph's Hospital and Medical Center, Phoenix

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-10-25

View on ClinicalTrials.gov More Ruptured Cerebral Aneurysm trials